Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

732744

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government, further to the Written Answer by the Parliamentary Under-Secretary of State, Department of Health, on 24 April (HC70973), when and how the Commission on Human Medicines "thoroughly review the data" on human papilloma virus (HPV) vaccine adverse reactions.
tabling member printed	The Countess of Mar
uin	HL182
answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Commission on Human Medicines (CHM) is the Government’s scientific advisory committee, from which the Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent scientific advice.</p><p> </p><p>The CHM considered a thorough review of the safety of human papillomavirus (HPV) vaccine at its meeting on 16 July 2015. Prior to 2015, the CHM considered reviews of HPV vaccine at meetings in September 2012, September 2010, September 2009, June 2009 and February 2009. These reviews included evaluation of United Kingdom Yellow Card reports, analysis of data from the Clinical Practice Research Datalink (CPRD), published safety studies and safety data from other countries.</p><p>Most recently, the CHM considered the safety of HPV vaccine at its meeting on 15 October 2015. At this meeting, the MHRA sought advice from the CHM on the (Co)-Rapporteurs’ assessment reports prepared for the European Medicines Agency (EMA) review into reports of postural orthostatic tachycardia syndrome and complex regional pain syndrome following HPV vaccine, in order to inform the UK position in the review.</p><p><strong> </strong>As with all vaccines and medicines, the safety of HPV vaccine remains under continual review by the MHRA.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 16:04:46 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

732745

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether, in the light of the significant increase in the number of cases of postural orthostatic tachycardia syndrome (POTS) reported as an adverse reaction to HPV vaccination since July 2015, they will ask the European Medicines Agency to review the safety signal.
tabling member printed	The Countess of Mar
uin	HL183
answer	answer is ministerial correction date of answer 03/07/2017 answer text <p>The European Medicines Agency (EMA) concluded a thorough review of reports of postural orthostatic tachycardia syndrome (POTS) following human papillomavirus (HPV) vaccine in November 2015, which found that the evidence did not support a causal association between HPV vaccination and POTS.</p><p> </p><p>As of 26 June 2017, the Medicines and Healthcare products Regulatory Agency (MHRA) has received 60 reports of POTS following HPV vaccine via the Yellow Card Scheme. More than three million girls have been vaccinated against HPV since 2008 across the United Kingdom, and the MHRA’s evaluation remains that the number of reports does not exceed what would be expected to occur in the absence of HPV vaccine and that the evidence does not suggest a causal association with the vaccine.</p><p> </p><p>The MHRA does not currently propose to ask the EMA to conduct a further review. As with the safety of all vaccines and medicines, this issue will remain under review.</p> answering member printed Lord O'Shaughnessy question first answered 03/07/2017 16:44:42 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

732746

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government who advised the Commission on Human Medicines that the available evidence does not support a causal association between HPV vaccination and development of postural orthostatic tachycardia syndrome (POTS) or complex regional pain syndrome (CRPS) according to the Commission's minutes of 15–16 October 2015; and why this statement was made before the European Medicines Agency Scientific Advisory Group (SAG) reported on 21 October 2015.
tabling member printed	The Countess of Mar
uin	HL184
answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Commission on Human Medicines (CHM) is the Government’s scientific advisory committee, from which the Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent scientific advice.</p><p> </p><p>Following a review of human papillomavirus (HPV) vaccine safety on 16 July 2015, the CHM advised the MHRA that the available evidence does not support a causal association between HPV vaccination and development of postural orthostatic tachycardia syndrome (POTS) or complex regional pain syndrome (CRPS), as well as other chronic illnesses. The public minutes of this meeting were made available online on 18 November 2015.</p><p> </p><p>At its meeting on 15 October 2015, the MHRA sought advice from the CHM on the (Co)-Rapporteurs’ assessment reports prepared for the European Medicines Agency (EMA) review into reports of POTS and CRPS following HPV vaccine, in order to inform the United Kingdom position in the review. The public minutes of this meeting were made available online on 21 December 2015.</p><p> </p><p>The CHM did not make a statement in October in advance of the EMA’s Scientific Advisory Group meeting. The CHM’s minutes were published on the above dates in line with usual practice and have informed the MHRA’s responses to enquiries about the safety of HPV vaccine.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 16:05:33 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

732747

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what assessment they have made of the implications that the European Court of Justice's decision in Case C–621/15 will have for UK claims for vaccine damage.
tabling member printed	The Countess of Mar
uin	HL185
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>The European Court of Justice’s decision on this case does not impact on the United Kingdom. This case relates to specific circumstances and law in France.</p> answering member printed Lord O'Shaughnessy question first answered 06/07/2017 15:54:04 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

712609

registered interest
date	20/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government upon what scientific basis the Expert Reference Group for the Joint Commissioning Panel for Mental Health (JCPMH), in publishing their guide on Commissioning for Medically Unexplained Symptoms (MUS), based their decision that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) should be categorised as a functional somatic disorder, given that the World Health Organisation’s mandatory International Classification of Diseases categorises the illness as neurological under ICD 10-G93.3, and that the National Institute for Health and Care Excellence (NICE) has not listed ME/CFS as a functional somatic disorder; and whether they will withdraw the recommendation for cognitive behaviour therapy and graded exercise to be commissioned for patients with ME/CFS until NICE Guideline CG53 is reviewed.
tabling member printed	The Countess of Mar
uin	HL6204
answer	answer is ministerial correction date of answer 28/03/2017 answer text <p>The Joint Commissioning Panel for Mental Health is not a Government body, it is a collaboration between 17 leading organisations including the Department of Health, and is co-chaired by the Royal College of Psychiatrists and the Royal College of General Practitioners. The Department was not closely involved in the writing or production of this document.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently reviewing the guidance GC53 to consider whether it should be updated to take account of new evidence. NICE are expected to reach a decision on whether the guidance should be updated in summer 2017.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy question first answered 28/03/2017 13:23:12 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

711998

registered interest
date	16/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 7 March (HL5683), whether the proposal submitted for chronic fatigue, for which there is no current classification, includes the current classification for G93.3 – post-viral fatigue syndrome and benign myalgic encephalomyelitis; and whether it is intended that those definitions will be included in ICD 11 under neurological conditions.
tabling member printed	The Countess of Mar
uin	HL6136
answer	answer is ministerial correction date of answer 28/03/2017 answer text <p>The World Health Organization (WHO) has reaffirmed with NHS Digital that the proposal submitted on the ICD-11 platform for chronic fatigue is currently with the relevant groups of the organisation to consider the scientifically-based placement in the classification. We understand that the WHO are still reviewing this matter and expect that the next iteration of ICD-11, expected in April 2017, will reflect the WHO’s conclusions.</p> answering member printed Lord O'Shaughnessy question first answered 28/03/2017 14:12:03 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

705853

registered interest
date	27/02/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neurology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they will ask the Joint Task Force responsible for overseeing the finalisation of the World Health Organisation International Classification of Disease ICD–11 to release, as a matter of urgency, the proposals of the Neurology Topic Advisory Group (Neurology TAG) for the classification of the ICD–10 G93.3 legacy terms for ICD–11.
tabling member printed	The Countess of Mar
uin	HL5683
answer	answer is ministerial correction date of answer 07/03/2017 answer text <p>NHS Digital has advised that its officials have discussed this matter with their counterparts at the World Health Organization (WHO). The WHO has confirmed that the latest version of the 11th Revision of the International Classification of Diseases (ICD-11) includes the Topic Advisory Group for Neurology’s proposals.</p><p> </p><p>The WHO has also confirmed that the proposal submitted for chronic fatigue is currently with the relevant groups of the organisation to consider the scientifically-based placement of this condition in the classification. This will be included in the next version of ICD-11 to be released on 4 April 2017 for field testing.</p> answering member printed Lord O'Shaughnessy question first answered 07/03/2017 12:25:12 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

693668

registered interest
date	23/02/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Records
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the NHS requires government departments and agencies, including the Department for Work and Pensions, the Health and Safety Executive and the Ministry of Defence, to pay for access to (1) patients’ medical records, and (2) other patient information, for use in legal proceedings, on the same basis as patients and lawyers representing patients.
tabling member printed	The Countess of Mar
uin	HL5572
answer	answer is ministerial correction date of answer 07/03/2017 answer text <p>The National Health Service may provide patient medical records and other patient information to a range of organisations for different purposes where there is a legal basis to share this information. This is subject to relevant legislation, guidance and codes of practice such as the Data Protection Act, common law duty of confidence and Confidentiality: NHS Code of Practice.</p><p> </p><p>General practitioners (GPs) provide medical certificates covered by the National Health Service (General Medical Services Contracts) Regulations 2004 without charge. They may charge a fee for other reports or requests for patient information.</p><p> </p><p>NHS Digital does not hold patient medical records in the same format as a GP or hospital. If NHS Digital is asked for a patient’s records or other patient information that it holds for use in legal proceedings by Government departments it will share this information if there is a legal basis to do so. It does not currently charge a fee for providing that information.</p> answering member printed Lord O'Shaughnessy question first answered 07/03/2017 12:20:59 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

675194

registered interest
date	18/01/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Liver Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what was the incidence of non-alcoholic fatty liver disease in humans in (1) 1990, (2) 1995, (3) 2005, and (4) 2015.
tabling member printed	The Countess of Mar
uin	HL4759
answer	answer is ministerial correction date of answer 27/01/2017 answer text <p>The data is not available in the format requested.</p> answering member printed Lord O'Shaughnessy question first answered 27/01/2017 12:09:25 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

674012

registered interest
date	17/01/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Aircraft: Air Conditioning
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether Public Health England plans to conduct tests on blood samples taken from passengers involved in a reported contaminated air incident aboard BA Flight 286 on 25 October 2016; and if not, why not.
tabling member printed	The Countess of Mar
uin	HL4736
answer	answer is ministerial correction date of answer 31/01/2017 answer text <p>The Centre for Disease Control and Prevention (CDC) in the United States was involved in the investigation of this event. Public Health England has confidence in any assessments done by the CDC, which is a highly competent authority that produces sound evidence-based advice.</p> answering member printed Lord O'Shaughnessy question first answered 31/01/2017 12:45:36 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar